Omega Healthcare Investors (OHI) Return on Sales (2009 - 2026)

Omega Healthcare Investors has disclosed Return on Sales across 17 years of filings, most recently posting 0.24% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.24%, up 24.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Sales came in at 0.24% for Q1 2026 at Omega Healthcare Investors, up from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.24% in Q1 2026 to a low of 0.0% in Q1 2023.
• The 5-year median for Return on Sales is 0.0% (2025), against an average of 0.02%.
• Across the five-year window, Return on Sales fell 16 bps in 2022 and grew 24 bps in 2026, its largest moves.
• Omega Healthcare Investors' Return on Sales stood at 0.0% in 2022, then fell by 26 bps to 0.0% in 2023, then soared by 72 bps to 0.0% in 2024, then grew by 28 bps to 0.01% in 2025, then jumped by 4455 bps to 0.24% in 2026.
• The last three Return on Sales figures came in at 0.24% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.